The Outcomes of Arteriovenous Fistula Cannulated From Different Direction.

May 19, 2015 updated by: Dongliang Zhang, MD

The Outcomes of Arteriovenous Fistula (AVF) Cannulated From Different Direction in Maintenance Hemodialysis Patients.

The investigators hypothesis that aneurysms and stenoses will be decreased if the direction of inserted arterial needle were same as the direction of blood flow, when compared to the opposite direction puncture.

Study Overview

Detailed Description

Native arteriovenous fistula (AVF) is the preferred access for hemodialysis, and cannulation technique is very important factors affect the outcomes of AVF. Rope-ladder cannulation is one kind of the standard puncture techniques which is used commonly in maintenance hemodialysis (MHD) patients. There are many complications for rope-ladder cannulation, such as venous aneurysm and vascular stenosis, which may induce AVF dysfunction. For the venous outflow way, there always be aneurysm followed by stenoses at the sites of needle connected with the arterial line in rope-ladder cannulation patients. The investigators hypothesis that the directions of inserted arterial needles should affect the AVF outcomes. The present prospective study will compare the outcomes of AVF between the puncture direction at arterial needle sites same as blood flow and opposite to blood flow.

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Beijing
      • Beijing, Beijing, China, 100050
        • Beijing Friedship Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 85 years (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • MHD patients with autogenous AVF.
  • Newly setup AVF in 3 months.
  • Fore- or Upper arm AVF.
  • Flow of >800ml/min detected by using the ultrasound dilution technique.

Exclusion Criteria:

  • AVF after neoplasty.
  • Arteriovenous grafts.
  • Anticipated live time less than one year.
  • Patients whose concurrent illnesses, disability, or geographical residence would hamper attendance at required study visit.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: PREVENTION
  • Allocation: RANDOMIZED
  • Interventional Model: PARALLEL
  • Masking: NONE

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
EXPERIMENTAL: Same direction cannulation
The inserted direction of arterial needle is same as the direction of blood flow.
The puncture direction of the arterial needle is same as the blood flow in every hemodialysis session.
ACTIVE_COMPARATOR: Opposite direction cannulation
The inserted direction of arterial needle is opposite to the direction of blood flow.
The puncture direction of the arterial needle is opposite to the blood flow in every hemodialysis session.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Prevalence of AVF aneurysm and stenosis.
Time Frame: 12 months
Compare the prevalence of AVF aneurysm and stenosis between two groups during 12 months.
12 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Proportions of AVF dysfunction in different groups.
Time Frame: 12 months
Compare the proportions of AVF dysfunction between two groups during 12 months.
12 months
The size of venous aneurysm.
Time Frame: 12 months
Measure the maximum size of venous aneurysm by using ultrasonography at month 12.
12 months
Diameter of venous stenosis.
Time Frame: 12 months
Measure the minimum diameter of venous stenosis by ultrasonography at month 12.
12 months
Percentages of unsuccessful cannulations.
Time Frame: 12 months
Unsuccessful cannulations include mis-cannulation, cannulation ease, hematoma, more than once cannulation at arterial site.
12 months
Events of AVF obstruction.
Time Frame: 12 months
AVF obstruction and the following treatments as central venous catheters and interventions will be recorded and compared between two groups during 12 months.
12 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Chair: Dongliang Zhang, Doctor, Kidney Disease Faculty of Capital Medical University
  • Study Director: Wenying Cui, Bachelor, Nephrology Department of Beijing Friendship Hospital

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

September 1, 2012

Primary Completion (ACTUAL)

April 1, 2013

Study Completion (ACTUAL)

April 1, 2013

Study Registration Dates

First Submitted

July 12, 2012

First Submitted That Met QC Criteria

July 13, 2012

First Posted (ESTIMATE)

July 17, 2012

Study Record Updates

Last Update Posted (ESTIMATE)

May 20, 2015

Last Update Submitted That Met QC Criteria

May 19, 2015

Last Verified

May 1, 2015

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Arteriovenous Fistula

Clinical Trials on Same direction cannulation

3
Subscribe